Bofutrelvir
Bofutrelvir (FB2001) is a SARS-CoV-2 main protease Mpro inhibitor with an IC50 value of 53 nM and an EC50 value of 0.53 μM. Bofutrelvir exhibits potent antiviral efficacy against several current SARS-CoV-2 variants with EC50 values of 0.26-0.42 μM. Bofutrelvir has an additive antiviral effect when combined with Remdesivir[2].
Product Specifications
CAS Number
2103278-86-8
Product Name Alternative
FB2001
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/bofutrelvir.html
Purity
96.0
Solubility
DMSO : 100 mg/mL (ultrasonic) |DMSO : 250 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(C(N1)=CC2=C1C=CC=C2)N[C@@H](CC3CCCCC3)C(N[C@H](C=O)C[C@H]4C(NCC4)=O)=O
Molecular Formula
C25H32N4O4
Molecular Weight
452.55
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
Phase 3
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Sulfolobus solfataricus Ribose-phosphate pyrophosphokinase (prs)
Recombinant Sulfolobus solfataricus Ribose-phosphate pyrophosphokinase (prs)